Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGulf Marine Services Regulatory News (GMS)

Share Price Information for Gulf Marine Services (GMS)

Share Price is delayed by 15 minutes
Get Live Data
18.74    -0.24 (-1.26%)
Bid:
18.64
Ask:
18.78
Spread: 0.14 (0.751%)
Market Cap: £215.92m
GMS Live PriceLast checked at - London Stock Exchange

Intraday Gulf Marine Services Share Chart

Pre - Stabilisation Notice

14 Mar 2014 07:00

RNS Number : 3190C
Gulf Marine Services PLC
14 March 2014
 



 

PRE-STABILISATION ANNOUNCEMENT

 

14 March 2014

RNS Number:

Gulf Marine Services PLC

 

Not for distribution, directly or indirectly, in or into the United States, Canada, Australia, Japan,

the United Arab Emirates, South Africa or any jurisdiction in which such distribution would be unlawful.

 

Gulf Marine Services PLC

Stabilisation Notice

 

Merrill Lynch International (contact: Michael Dadoun; telephone: +44 (0) 20 995 3700) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The securities:

Issuer:

Gulf Marine Services PLC

Securities:

Ordinary Shares of 10 pence each (ISIN: GB00BJVWTM27)

Offering Description

Initial Public Offering

Offering Size:

122,735,402 shares

Offer Price:

135 pence per share

Stabilisation:

Stabilisation Manager:

Merrill Lynch International

Stabilisation period expected to start on:

14 March 2014 at approximately 8am

Stabilisation period expected to end no later than:

11 April 2014 COB

Over-allotment Option:

Existence and conditions of use of over-allotment facility:

The Stabilisation Manager(s) may over-allot the securities to the extent permitted in accordance with applicable law.

% Size of over-allotment facility

15%

Maximum size of over-allotment facility

18,317,849 number of shares

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAGLGDXDSBBGSS
Date   Source Headline
7th Jun 20231:15 pmRNSResult of AGM
10th May 20234:46 pmRNSDirector / PDMR Shareholdings
4th May 20237:00 amRNSHealth & Safety Milestone
28th Apr 20235:02 pmRNSAnnual Report and Notice of AGM
24th Apr 20237:00 amRNSFinal Results
29th Mar 20237:00 amRNSContract
10th Feb 20237:30 amRNSDirector/PDMR Shareholding
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSContract
13th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSTrading Statement
3rd Jan 20237:00 amRNSIssue of Warrants
14th Dec 20227:00 amRNSWarrant Calculations
9th Dec 20227:00 amRNSTrading Update
25th Nov 202211:37 amRNSHolding(s) in Company
15th Nov 20227:00 amRNSContract
3rd Nov 20227:00 amRNSTwo New Contract Awards and A Contract Extension
19th Oct 20223:10 pmRNSResults of General Meeting
29th Sep 20227:00 amRNSContract
28th Sep 20225:04 pmRNSPublication of Shareholder Circular & Notice of GM
27th Sep 20227:00 amRNSContract
26th Sep 20227:00 amRNSInterim results for the six months ended 30/06/22
1st Sep 20224:40 pmRNSSecond Price Monitoring Extn
1st Sep 20224:35 pmRNSPrice Monitoring Extension
30th Jun 20221:10 pmRNSResult of AGM
15th Jun 20227:30 amRNSGrant of Director Share Awards
7th Jun 20225:30 pmRNS2021 Annual Report and Notice of 2022 AGM
13th May 20227:10 amRNSAnnual Financial Report
29th Apr 20227:00 amRNSContract
17th Feb 20227:00 amRNSContract
7th Feb 20227:00 amRNSAppointment of Chief Financial Officer
1st Feb 20228:09 amRNSDirector/PDMR Shareholding
25th Jan 20227:00 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSTrading Update
21st Dec 20217:00 amRNSContract
20th Dec 20214:41 pmRNSSecond Price Monitoring Extn
20th Dec 20214:36 pmRNSPrice Monitoring Extension
13th Dec 20214:41 pmRNSSecond Price Monitoring Extn
13th Dec 20214:35 pmRNSPrice Monitoring Extension
11th Nov 20217:00 amRNSContract
4th Nov 20214:40 pmRNSSecond Price Monitoring Extn
4th Nov 20214:35 pmRNSPrice Monitoring Extension
21st Oct 20217:00 amRNSContract
13th Oct 20213:17 pmRNSShare Purchase by a Director
13th Oct 20217:00 amRNSHalf-year Report
1st Oct 20217:00 amRNSResults Release Date & Trading Update
23rd Aug 20217:00 amRNSAppointment of Non-Executive Director
8th Jul 20211:08 pmRNSDirector/PDMR Shareholding
5th Jul 20212:02 pmRNSDirector/PDMR Shareholding
5th Jul 202110:52 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.